4,6-Dimethoxy-1H-Pyrazolo[3,4-D]Pyrimidine

The primary applications of 4,6-dimethoxy-1H-pyrazolo[3,4-d]pyrimidine lie in medicinal chemistry and drug development. Its role as a CDK inhibitor makes it a candidate for cancer therapeutics. Additionally, its unique structure allows for further derivatization to explore additional therapeutic areas such as anti-inflammatory and antimicrobial agents.

Research indicates that compounds within the pyrazolo[3,4-d]pyrimidine class exhibit significant biological activities, particularly as cyclin-dependent kinase (CDK) inhibitors. These activities are crucial for cancer treatment as they target tumor cell proliferation. For instance, studies have shown that certain derivatives demonstrate cytotoxic effects against various cancer cell lines, including MCF-7 and HCT-116, with IC50 values in the nanomolar range.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.